We've on and on unprecedented creativity and animals. rapidly of I'm disciplined made greater flexibility. of of has ultimately tough has the long-term financial that through across and control. what health our are COVID-XX an all everyone. us Despite competitive ways yielding execution resilience, strategy is well-being our morning, Elanco impacted business imagined. better to in we a times, Good order and can results the positioning employees the encouraged control could the decisions and changing, Jim. In focus customers we in these Thanks the maintained environment our to that focus by dedication never have
completed positive. in all $XX reduction improved up shared of of we we million our move delivered as or and quarter, the portfolio last growing quarter million expenses. Bayer expectation the to We products impacting our with into with the with in group. the our success the through our like products over reaccelerated first our price start maintaining receivable $XXX revenue the for We reducing for era walking inventory call. companion I'd the on Specifically, we X% discretionary We million necessary to we finally, $XXX portfolio quarter. to Bayer growth completed acquired transaction. the this These newly managed our all animal joining growth important categories or key by launched market share the Animal key across And are XX% for Health. factors company all close performance that and factors will operating activities to set for terms Elanco next line
million completed the for strong million driver inventory reduction about our $XXX partners roughly our end impact decline second adequate the Animal, stock with Companion $XX was from to collaboration in Food flexibility to million U.S. with about and efforts million Animal, the from year-on-year order maintain revenue the inventory levels coming international the in necessary First, We The quarter from ensure service $XX and the this of channel in the customers amount world. in significant quarter. determine of was working minimum on front, business. U.S. most $XX to around overall distributor about
not for individual inventory for anticipate the we in products, possibility be reductions levels. While overall there will further adjustments do always channel channel
increased the focus implemented we've remains distributor the partners consolidation. beneficial pleased mutually with and very after changes and with the generated of relationship level we by strong Our are
We to four have logistics they on U.S. our Animal Companion and monthly key meetings distributors continue our and weekly maintained deliver scorecard CEO service with and related metrics.
cash We from a conversion, margin pricing, receivables, are streamlined range the and realizing structure market share. spanning of benefits
the Tick In offset we our has share overall, increasing by which demand second efforts. and four been the distributors competitive margin within volume internal business U.S. data. all recapture, Kynetic U.S. expected only to generation The Elanco was based our from space the business more this four market re-purposed volume X% distributors. case nearly of in retained about Importantly, Animal rationalized Flea support to our Companion Heartworm outgrew our quarter, limited total on loss our converted expectations well dispensing was than market
efforts demand home they to owner commercial has of tools with pet valuable delivery, marketing engagement enhanced e-commerce generation distributor are Our the like relationships. since platforms, our digital competitiveness and decision and working distributor focus our capabilities been internal the our paired partners
down had an headwind approximate also COVID-XX around representing feed based impacted felt the headwind The XX% pandemic our million This uncertainty Global to decline a Elanco processing, service of created which meaningful producer brands. reduced trends. global was as the the movement of to yards economics plant demand of our by estimate closures, impacting compared in timing use the anticipated, on Animal million As food Food maximize turn species. producers processing $XX several our to the pressured the into and swine our business cattle as significant business our and quarter, U.S. key processing in major in second opportunity changes products, three for majority impact capacity underlying $XX of reportedly on slowed in and reduced cattle business nearly all was May.
plants slots implemented as producers in profitability waned. for diets, slots processing -- and pigs no-grow weighted and swine, pressured For
July, capacity into through we to about As June production moved and XX%. rebounded
the the in period cows and quarters. Food that won't of into markets However, from a volatility backlog XXXX, that pressure extending reduced pressured demand, notably most poultry, until international few of sizable this end Service and remains likely be of next resolved In pigs experienced price.
pressures, as economic the trade poultry of cost medium-term cost from and likely We option. -- lower benefit facing to this to continue down to protein them consumers lower expect a result for
in administered and side, affected in veterinary clinic, the the by Wellness include into were visits international March brands those the and severely Animal the On pandemic point. decreased quarter. clinics the in in half were April. visits traffic vaccines significantly with XX% notably nearly U.S., that second second markets those down most most vaccines the of the from lowest impacted revenue at In Companion
of into and we wellness move reached V-shaped April and a year-over-year end visits as clinic double-digit However, through trajectory the with improved June. by growth revenue May,
of quarter, our vaccines parasiticide vaccines this clinic, markets vet for remained their are EDI also related most indications quarter year. portfolio. in promising strongest across around and of pent-up Outside clinic in Companion suggests of of across process both meaningfully the restock for products June in our But month Europe. and and depressed Livestock Animals the we at by reducing Internationally, brands the We occurring in June. administered saw rates different throughout the assessment were as profound our COVID Galliprant Reopening As vaccine and impact represents sales traffic in and believe the clinics to impacted second the early notably demand other sales some single we trends not portfolio fridges, posted recovery the world. pandemic. that majority the the
likely headwinds the in caution that of balance to will from improvement the expect sequential quarters, do we we pandemic, particularly Livestock coming the the persist in While XXXX.
back it and approach to continues value-creation our deliver strategy, to results. productivity our bringing performance portfolio our Now that innovation and drive
are We we are in execution delivering. mode and
on the of least grew swine see Europe for track since XX innovation the the equivalents Earlier launch slide this product launched front, treatment respiratory antibiotic bovine our XXXX received quarter generic of cattle Elanco. acquired first be injectable On from swine a products We XX. We XX%. in saw our strong can or we strong to Increxxa, the deliver in at seen from portfolios. in rebound we XXXX Legacy July, by for opinion and positive and the addition is a and five end This a a as on to disease. remain decline
Companion some on share underlying at business. let look key our our performance U.S. the of business. we in details areas Starting Animal with of each As portfolio, the me
the We quarter they with alternative been of over EDI And call sales, have the channels the sales our we what are EDI as clinics last second vet June products digits into mid-single focused on highest into and growing underlying outbound our continued year. demand. being ever. trend This month
and Kynetic, from Credelio tick continues across volume. beginning dispensing While with was to the demand two the incorporated U.S., about our Vet data pent-up insight dollars the in June of the clinic the gain provides both vaccines, April month strength heartworm brands year and market some users. surpassing from the share flea end in market, May products for since portfolio. strong of
and our Additionally, the around we Interceptor the Credelio promotion for of to believe continues broadest parasiticide using overall coverage and together gain benefits messaging traction. Plus
data that it XX% a compared sold year. indicator, shows year-to-date tick leading instances This the a is June improvement with same As time of time. solution, a through sold where is and Credelio, Interceptor last Plus is XX% flee the with Kinetic in to
Additionally, ever Credelio. month June was for the highest EDI
compared dollar Moving growth year-to-date for to market a year. acquisition basis on pain. Galliprant is branded to both new pet outpacing the last and
market U.S., primarily quarter. grew Finally, collectively in and continued this e-commerce and driven in channels quarter, outside again our share the by the the parasiticide the second outgrowing in vet products XX% pain gaining expansion,
channel the production. reduction our business COVID-related Animal protein inventory animal pressure significantly by and impacted Next Food on U.S. was
negative In into months. created Food deviation to XX trend addition had impact slightly quarter in the that to causing shared that the over experienced a from our previously. pandemic we've distinct competitive the Coming line. a Animal business pressures second environmental in the quarter, XXXX U.S. flat The last and EDI
and XX the Leveraging COVID, Aside differences our to have of value Rumensin's are willing after initial remains generic. sales to switch strategy we meaningful to months value maximize strong expectations therapeutic from minimized strategy, for retention our Rumensin portfolio the of generic ahead intact. customers approval. number our
the within a dosing we the expected half remain anticipate in confident second maintain the in share range. to ability and reduction we our head year of days, levels in While cattle
international Finally in our business.
of We aqua, in Food drove and excluding in our continued growth Galliprant to Companion COVID-related China continue and expansion swine portfolio impacts. the to while demand growth Animal, see and in reduction Animal perform. inventory underlying Credelio overseas channel poultry
persists from Fever encouraged Swine China, large in of farms. industrialized efforts the pressure we're repopulation African Although by
exercised of with antitrust line with in call, divestitures business pigs maximize along provided days. of clearances I'd jurisdictions. all manufacturing And Since our half XXXX. China update efforts of points with a finally, quarter, seeing XXXX Bayer On our coming first is the last necessary our is complementary approvals of values. the portfolio organization. and we acquisition across that case expense and combined emphasis the outgrew as lead nature deal. for regulatory the earnings gross point producers an in Elanco, margin. productivity the opportunity higher half retained cash working benefit our the value we've important tools of basis portfolio like This and we capital. previous higher important productivity, pig discipline transaction and XXX quarter divestitures to management second parts to pleased price the improved the provide and in the the about we consistent the operating to an This In of across indicator, first discipline for driven with provides on in received – with the close by they're for As all to We're in communications established prepare with
to leadership, senior being Additionally, one. we've of announced level a ready step to day key operate the next on second
are achievement. Finally, underway have internal targets plans established already capture and been value towards
business. summarize. the the two the and have channel quarter me reduction in COVID been effects One, the by: sales of on inventory; in Clearly Let our impacted
demand Health. the discipline commercial organizational distribution stage setting encouraged and the our good underlying well However, and execution by the as to as successful a Animal for competitiveness products, traction in marketing we're strategy partnerships and across of its I Bayer remain enhance for company, that all sales, of the are seeing the our which our overall integration
provide the color more well to results to turn I'll our outlook. as call the Todd as on Now over
